Persivia, the company behind one of the healthcare industrys most advanced digital health platforms, today announced two major developments-a 107M investment from Aldrich Capital Partners and the issuance of U.S. Patent No. 12,254,975 B2 for its Health Data Processing System. This dual milestone signals a new era for healthcare, as Persivia prepares to scale its proven AI-first platform and transform how care is delivered, measured, and managed across the continuum.
The newly granted patent protects the core AI capabilities behind CareSpace, Persivias modular digital health platform. Unlike typical platforms that merely surface data, CareSpace uses Soliton, a now-patented AI engine to ingest, analyze, prioritize, and deliver actionable insights in real time. This allows care teams to respond to the most urgent needs, manage complex patient populations, and streamline workflows-all from a unified interface.
Solving healthcares toughest challenges with an AI core that is now patented, proven, and deployed at scale.
Aldrichs investment-completed at the end of February-provides the financial firepower to expand quickly and invest deeply in platform innovation, client success, and go-to-market execution.
It also puts Persivia in a position few companies can claim: deeply funded, clinically validated, and now legally protected as the innovator of a patented AI-driven platform.